Blood component therapy and massive transfusion

Shiu Ki Rocky Hui, Kjersti Marie Aagaard, Jun Teruya

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter is intended as an aid to understanding the preparation of, indications for, and potential complications of blood components for obstetric critical care. The term blood component therapy refers to the use of specific components of whole blood for a specific patient’s needs. Long-term storage of frozen red blood cells (RBCs) may be necessary for those individuals who have rare blood types and for some autologous donors. The purpose of a red cell transfusion is to restore oxygen-carrying capacity in order to maintain adequacy of tissue oxygenation. Massive transfusion is defined as the replacement of one or more blood volumes within 24 hours. Acute normovolemic hemodilution (ANH) refers to the collection of 1 or more units of whole blood just before initiating surgery followed by the reinfusion of this blood at the end of surgery. An acute hemolytic transfusion reaction (AHTR) occurs when RBCs containing antigens to existing antibodies in recipient plasma are transfused.

Original languageEnglish (US)
Title of host publicationCritical Care Obstetrics
PublisherWiley
Pages547-568
Number of pages22
ISBN (Electronic)9781119129400
ISBN (Print)9781119129370
DOIs
StatePublished - Jan 1 2018

Keywords

  • Acute hemolytic transfusion reaction
  • Acute normovolemic hemodilution
  • Blood component therapy
  • Massive transfusion
  • Rbcs

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Blood component therapy and massive transfusion'. Together they form a unique fingerprint.

Cite this